Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya

Malaria Journal

Volumn 2, Issue , 2003, Pages 1-7

  Chelimo, Kiprotich ^a,b   Sumba, Peter O ^b   Kazura, James W ^c   Ofula, Ayub V ^a   John, Chandy C ^c  

^a MASENO UNIVERSITY   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD STAGE ANTIGEN; ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; LIVER STAGE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDEMIC DISEASE; GROUPS BY AGE; HUMAN; INFANT; KENYA; MALARIA; MORBIDITY; ONSET AGE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PREVALENCE; PROTEIN BLOOD LEVEL; RESPONSE TIME; T LYMPHOCYTE;

EID: 3042685259     PISSN: 14752875     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2875-2-1     Document Type: Article

References (22)

1. Bloland PB, Boriga DA, Ruebush TK, McCormick JB, Roberts JM, Oloo AJ, Hawley W, Lal A, Nahlen B and Campbell CC: Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg 1999, 60:641-648.
2. Troye-Blomberg M, Berzins K and Perlmann P: T-cell control of immunity to the asexual blood stages of the malaria parasite. Crit Rev Immunol 1994, 14:131-155.
3. Aidoo M, Lalvani A, Gilbert SC, Hu JT, Daubersies P, Hurt N, Whittle HC, Druihle P and Hill AV: Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect Immun 2000, 68:227-232.
4. Doolan DL and Hoffman SL: IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J Immunol 1999, 163:884-892.
5. John CC, Sumba PO, Ouma JH, Nahlen BL, King CL and Kazura JW: Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. Infect Immun 2000, 68:5198-5204.
6. Kurtis JD, Lanar DE, Opollo M and Duffy PE: Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infect Immun 1999, 67:3424-3429.
7. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Ulbert S, Migot-Nabias F, Dubois B, Deloron P and Kremsner PG: Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria. Eur Cytokine Netw 1998, 9:639-646.
8. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Migot-Nabias F, Deloron P, Nussenzweig RS and Kremsner PG: Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 1999, 179:980-988.
9. Connelly M, King CL, Bucci K, Walters S, Genton B, Alpers MP, Hollingdale M and Kazura JW: T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect Immun 1997, 65:5082-5087.
10. Perlmann P and Troye-Blomberg M: Malaria blood-stage infection and its control by the immune system. Folia Biol (Krakow) 2000, 46:210-218.
11. Quakyi IA, Currier J, Fell A, Taylor DW, Roberts T, Houghten RA, England RD, Berzofsky JA, Miller LH and Good MF: Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. J Immunol 1994, 153:2082-2092.
12. Riley EM, Allen SJ, Wheeler JG, Blackman MJ, Bennett S, Takacs B, Schonfeld HJ, Holder AA and Greenwood BM: Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 1992, 14:321-337.
13. Kabilan L, Sharma VP, Kaur P, Ghosh SK, Yadav RS and Chauhan VS: Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic. Infect Immun 1994, 62:685-691.
14. Egan A, Waterfall M, Pinder M, Holder A and Riley E: Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect Immun 1997, 65:3024-3031.
15. Hollingdale MR, McCormick CJ, Heal KG, Taylor-Robinson AW, Reeve P, Boykins R and Kazura JW: Biology of malarial liver stages: implications for vaccine design. Ann Trop Med Parasitol 1998, 92:411-417.
16. Ong'echa JM, Lal AA, Terlouw DJ, Ter Kuile FO, Kariuki SK, Udhayakumar V, Orago AS, Hightower AW, Nahlen BL and Shi YP: Association of interferon-gamma responses to pre-erythrocytic stage vaccine candidate antigens of Plasmodium falciparum in young Kenyan children with improved hemoglobin levels: XV. Asembo Bay Cohort Project. Am J Trop Med Hyg 2003, 68:590-597.
17. Hoffman SL and Doolan DL: Malaria vaccines-targeting infected hepatocytes. Nat Med 2000, 6:1218-1219.
18. Jinquan T, Larsen CG, Gesser B, Matsushima K and Thestrup-Pedersen K: Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol 1993, 151:4545-4551.
19. Diallo TO, Nguer CM, Dieye A, Spiegel A, Perraut R and Garraud O: Immune responses to P. falciparum-MSP1 antigen: lack of correlation between antibody responses and the capacity of peripheral cellular immune effectors to respond to this antigen in vitro. Immunol Lett 1999, 67:217-221.
20. Matsumoto S, Yukitake H, Kanbara H and Yamada T: Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J Exp Med 1998, 188:845-854.
21. Matsumoto S, Yukitake H, Kanbara H and Yamada T: Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting mero-zoite surface protein-1. Vaccine 1999, 18:832-834.
22. Bongartz M, Rezbach P, Borrmann S, Hollingdale MR, Kremsner PG and Luty AJ: Age-dependent enhancement of IFN-gamma responses to Plasmodium falciparum liver stage antigen-1 T cell epitopes. Parasitol Res 2002, 88:1083-1089.